Sleep disorders in Parkinson disease

Neurologist

Volumn 17, Issue 6 SUPPL., 2011, Pages

  Iranzo De Riquer, Alex ^a,b   Bergareche, Alberto ^c   Campos, Victor ^d  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Hospital del Bidasoa   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

excessive daytime sleepiness; Parkinson disease; REM sleep behavior disorder; Sleep disorders

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; GABAPENTIN; IRON; LEVODOPA; MELATONIN; METHYLPHENIDATE; MODAFINIL; OREXIN; OXYBATE SODIUM; PARKIN; PRAMIPEXOLE; PREGABALIN; ROPINIROLE; ROTIGOTINE;

ADD ON THERAPY; ANXIETY; ARTICLE; BEDTIME DOSAGE; BRAIN DEPTH STIMULATION; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DRUG HALF LIFE; DYSKINESIA; ELECTROMYOGRAPHY; EXERCISE; HUMAN; IMPOTENCE; LIMBIC SYSTEM; LOW DRUG DOSE; PARASOMNIA; PARKINSON DISEASE; PATIENT ASSESSMENT; PRIORITY JOURNAL; REM SLEEP; RESTLESS LEGS SYNDROME; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP PATTERN; SLEEP QUALITY; SLEEP STAGE; SUBTHALAMIC NUCLEUS; URINE INCONTINENCE;

HUMANS; PARKINSON DISEASE; SLEEP DISORDERS;

EID: 80455131092     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31823966f8     Document Type: Article

References (33)

1. Grandas F, Iranzo A. Nocturnal problems occurring in Parkinson's disease. Neurology. 2004;63(8 Suppl 3):S8-11.
2. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord. 1998;13:895-899.
3. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord. 2009;24: 1641-1649.
4. Hogl B, Arnulf I, Comella C, et al. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord. 2010;25:2704-2716.
5. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson's disease sleep scale: A new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002;73:629-635.
6. Marinus J, Visser M, van Hilten JJ, et al. Assessment of sleep and sleepiness in Parkinson disease. Sleep. 2003;26:1049-1054.
7. Martinez-Martin P, Visser M, Rodriguez-Blazquez C, et al. and PDSS: Two scales for assessment of sleep disorder in Parkinson's disease. Mov Disord. 2008;23:1681-1688.
8. Hagell P, Broman JE. Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson's disease. J Sleep Res. 2007;16:102-109.
9. Diederich NJ, Vaillant M, Mancuso G, et al. Progressive sleep "destructuring" in Parkinson's disease: A polysomnographic study in 46 patients. Sleep Med. 2005;6:313-318.
10. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009; 72(21 Suppl 4):S1-136.
11. Iranzo A, Valldeoriola F, Santamaria J, et al. Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2002;72:661-664.
12. Rye DB, Bliwise DL, Dihenia B, et al. Fast track: Daytime sleepiness in Parkinson's disease. J Sleep Res. 2000;9:63-69.
13. Alves G, Wentzel-Larsen T, Aarsland D, et al. Progression of motor impairment and disability in Parkinson disease: A population- based study. Neurology. 2005;65:1436-1441.
14. Compta Y, Santamaria J, Ratti L, et al. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia. Brain. 2009;132(Pt 12):3308-3317.
15. Kaynak D, Kiziltan G, Kaynak H, et al. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol. 2005;12:199-207.
16. Montastruc JL, Brefel-Courbon C, Senard JM, et al. Sleep attacks and antiparkinsonian drugs: A pilot prospective pharmacoepidemiologic study. Clin Neuropharmacol. 2001;24:181-183.
17. Homann CN, Wenzel K, Suppan K, et al. Sleep attacks in patients taking dopamine agonists: Review. BMJ. 2002;324:1483-1487.
18. Cochen De Cock V, Abouda M, Leu S, et al. Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med. 2010;11: 247-252.
19. Iranzo A, Santamaria J, Tolosa E. The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev. 2009;13:385-401.
20. Kumru H, Santamaria J, Tolosa E, et al. Rapid eye movement sleep behavior disorder in parkinsonism with parkin mutations. Ann Neurol. 2004;56:599-603.
21. Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology. 2002;59:585-589.
22. Iranzo A, Santamaria J, Rye DB, et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology. 2005;65:247-252.
23. Iranzo A, Santamaria J, Vilaseca I, et al. Absence of alterations in serum sex hormone levels in idiopathic REM sleep behavior disorder. Sleep. 2007;30:803-806.
24. Kumru H, Santamaria J, Tolosa E, et al. Relation between subtype of Parkinson's disease and REM sleep behavior disorder. Sleep Med. 2007;8:779-783.
25. Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study. Lancet Neurol. 2006;5:572-577.
26. Iranzo A, Comella CL, Santamaria J, et al. Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system. Mov Disord. 2007;22(Suppl 18): S424-S430.
27. Dusek P, Buskova J, Ruzicka E, et al. Effects of ropinirole prolonged release on sleep disturbances and daytime sleepiness in Parkinson disease. Clin Neuropharmacol. 2010;33: 186-190.
28. Trenkwalder C, Kies B, Rudzinska M, et al. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord. 2011;26:90-99.
29. Suchowersky O, Furtado S, Rohs G. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease. Mov Disord. 1995;10:337-340.
30. Ondo WG, Perkins T, Swick T, et al. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: An open-label polysomnographic study. Arch Neurol. 2008;65:1337-1340.
31. Dowling GA, Mastick J, Colling E, et al. Melatonin for sleep disturbances in Parkinson's disease. Sleep Med. 2005;6:459-466.
32. Medeiros CA, Carvalhedo de Bruin PF, Lopes LA, et al. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease: A randomized, double blind, placebocontrolled study. J Neurol. 2007;254:459-464.
33. Kumru H, Iranzo A, Carrasco E, et al. Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease. Sleep. 2008;31:1418-1421.